Gts Securities »

Crispr Therapeutics shares owned by Gts Securities

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Gts Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $10M 151k 68.16
2023-12-31 $15M 232k 62.60
2023-09-30 $7.0M 154k 45.39
2023-06-30 $1.5M 28k 56.14